Your browser doesn't support javascript.
loading
Uso de fibrinolíticos en el tromboembolismo pulmonar (TEP) ¿Qué? ¿Cuándo? ¿Cuánto? / Fibrinolytic treatment in pulmonary thromboembolism. What to use? When? How much?
Ceresetto, José M; Sánchez Avalos, Julio; Ubaldini, Jorge.
Afiliação
  • Ceresetto, José M; Hospital Británico. Servicio de Hematología.
  • Sánchez Avalos, Julio; Instituto Alexander Fleming. Servicio de Hematología.
  • Ubaldini, Jorge; Hospital Británico. Servicio Terapia Intensiva.
Hematología (B. Aires) ; 5(3): 217-221, nov.-dic. 2001. tab
Article em Es | LILACS | ID: lil-341386
Biblioteca responsável: AR67.1
ABSTRACT
Severe pulmonary ambolism with sustained hypontension (less than 90 mmHg systolic pressure) or with cardiogenic shock requires urgent treatment with fibrinolytic drugs. Otherwise there is still no consensus with the use of fibrinolytics in patients witch are compensated but with right ventricular disfunction and even Dr. Goldhaber now seems to be cautious because of the high risk of intracraneal bleeding. The suggested dose is for t-PA 100 mg. IV in 2 hours, UK 1 millon U IV in 10 minutes and then 2 millons in 2 hours, SK 1.5 millon U. IV in 2 hours.
Assuntos
Buscar no Google
Índice: LILACS Assunto principal: Embolia Pulmonar Idioma: Es Revista: Hematología (B. Aires) Assunto da revista: HEMATOLOGIA Ano de publicação: 2001 Tipo de documento: Article
Buscar no Google
Índice: LILACS Assunto principal: Embolia Pulmonar Idioma: Es Revista: Hematología (B. Aires) Assunto da revista: HEMATOLOGIA Ano de publicação: 2001 Tipo de documento: Article